Archives
Calpain Inhibitor I (ALLN) Overview
Product identity
Calpain Inhibitor I, ALLN is listed by APExBIO as SKU A2602 and CAS 110044-82-1. The supplier describes it as a small-molecule inhibitor with activity against calpain I, calpain II, cathepsin B, and cathepsin L.
Conceptual research scope
Based on the supplied product information, ALLN is positioned for protease-focused research involving apoptosis assay design, caspase activation studies, inflammation research, and ischemia-reperfusion injury model investigations. These descriptions indicate intended research contexts rather than established clinical or diagnostic applications.
Evidence limitations
No matched peer-reviewed paper evidence was supplied for this overview. Accordingly, the target profile and research-use context are reported as supplier-documented claims, not independently verified performance findings. Applicability may vary with biological system, assay design, compound handling, and selectivity requirements. The product should not be interpreted as a validated therapeutic, diagnostic reagent, or broadly selective calpain probe without additional evidence.